首页> Diabetes & metabolism journal> Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus.

Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus.

导出 OA

翻译打印收藏纠错

第一作者： Shinae,Kang

第一单位： Division of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

作者： Shinae,Kang ^[1] ; Yu-Bae,Ahn ^[2] ; Tae Keun,Oh ^[3] ; Won-Young,Lee ^[4] ; Sung Wan,Chun ^[5] ; Boram,Bae ^[6] ; Amine,Dahaoui ^[7] ; Jin Sook,Jeong ^[6] ; Sungeun,Jung ^[7] ; Hak Chul,Jang ^[8]

作者单位： Division of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. ^[1] Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. ^[2] Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea. ^[3] Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[4] Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea. ^[5] Novo Nordisk Pharma Korea Limited, Seoul, Korea. ^[6] Novo Nordisk Region Asia Pacific, Dubai, United Arab Emirates. ^[7] Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. ^[8]

关键词 Databases, factual Diabetes mellitus, type 2 Glycemic control Hypoglycemia Insulin degludec, insulin aspart drug combination